Abstract
Parathyroid carcinoma is the rarest type of endocrine malignant tumor. Consequently, clinicians and pathologists not dealing with endocrine tumors will have a limited experience, which may affect the diagnosis and treatment of this tumor. Its natural growth pattern is that of a slowly growing neoplasm, and when recurrences eventually occur they are predominantly located cervically. This fact may initially lead the surgeon to assume that the tumor is not malignant. The term atypical adenoma was coined for borderline lesions with a clinically benign course [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levin KE, Galante M, Clark OH. 1987. Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery 101:649–660.
Sandström IV. 1880. Om en ny körtel hos meniskan och åtskilliga däggdjur. Uppsala läkareförenings förhandlingar 15:441–471.
Erdheim J. 1906. Tetania parathyreopriva. Mitt Grenzgeb Med Chir 16:632–744.
Erdheim J. 1907. Öber Epithelkörperchenbefunde bei Osteomalacie. SB Akad Wiss Math naturw C1 116:311.
MacCallum WC. 1924. On the pathogenesis of tetany. Medecine 3:137–163.
Thompson NW. 1990. The history of hyperparathyroidism. Acta Chir Scand 156:5–21.
Wellbrock WLA. 1929. Malignant adenoma of the parathyroid glands. Endocrinology 13:285–294.
Wilder RM. 1929. Hyperparathyroidism: Tumor of the parathyroid glands association with osteitis fibrosa. Endocrinology 13:231–244.
Fujimoto Y, Obara T, Ito Y, Kanazava K, Aiyoshi Y, Nobori M. 1984. Surgical treatment of ten cases of parathyroid carcinoma: Importance of an initial bloc resection. World J Surg 8:392–400.
Cohn K, Silverman M, Corrado J, Sedgewick C. 1985. Parathyroid Carcinoma: The Lahey Clinic Experience. Surgery 98:1095–1100.
Mattei JF, Audiffret J, Henri JF, Roux H. 1988. Cancer des parathyroides. Revue Rhum Mal Osteoartic 55:519–523.
Sandelin K, Thompson NW, Bondeson L. 1991. Dilemmas in management of parathyroid carcinoma. Surgery 110:978–988.
Shortell CK, Andrus CH, Phillips CE, Schwartz SI. 1991. Carcinoma of the parathyroid gland: A 30 year experience. Surgery 110:704–708.
van Heerden JA, Weiland LH, Re Mine WH, Walls JT, Purnell DC. 1979. Cancer of the parathyroid glands. Arch Surg 114:475–480.
Obara T, Fujimoto Y. 1991. Diagnosis and treatment of patients with parathyroid carcinoma: An update and review. World J Surg 15:738–744.
Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. 1992. Prognostic factors in parathyroid cancer. A review of 95 cases. World J Surg 16:724–731.
Mc Keown PP, Mc Garity WC, Sewell CW. 1984. Carcinoma of the parathyroid gland: Is it overdiagnosed? Am J Surg 147:292–298.
Dinnen JS, Greenwood RH, Jones JH, Walker DA, Williams ED. 1977. Parathyroid carcinoma in familiar hyperparathyroidism. J Clin Pathol 30:966–975.
Frayah RA, Nasar VH, Dagher F, Salti IS. 1972. Familial parathyroid carcinoma. Leb Med J 25:299–309.
Malette LE, Bilezikian JP, Ketcham AS, Aurbach GD. 1974. Parathyroid carcinoma in familial hyperparathyroidism. Am J Med 57:642–648.
Leborgne J, Neel J-C, Buzelin F, Malvy P. 1975. Cancer familial des parathyroïdes. Intérét de l’angiographie dans le diagnostic des récidives locorégionales. J Chir (Paris) 109:315–326.
Visset J, Letissier E, Perchenet AS, Fiche M, Hamy A, Paineau J. 1992. Forme familiale de cancer primitif des glandes parathyroïdes. Chirurgie 118:223–228.
Streeten E, Weinstein LS, Norton JA, Mullvihill JJ, While BJ, Friedman E, Jaffe G, Brandi ML, Stewart K, Zimering MB, Spiegel AM, Aurbach GD, Marx SJ. 1992. Studies in a kindred with parathyroid carcinoma. J Clin Endocrinol Metab 75:362–366.
Hendy GN, Arnold A. Molecular basis of PTH overexpression. In Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology, San Diego, CA: Academic Press, in press.
Fujiwara S, Sposto R, Ezaki H, et al. 1992. Hyperparathyroidsim among atomic bomb survivors in Hiroshima. Radiat Res 130:372–378.
Katz A, Braunstein GD. 1983. Clinical, biochemical, and pathologic features of radiation associated hyperparathyroidism. Arch Intern Med 143:79–82.
Obara T, Okamoto T, Yamashita T, Kawano M, Nishy T, Tani M, Sato K, Demura H, Fuijimoto Y. 1993. Surgical and medical management of patients with pulmonary metastases from parathyroid carcinoma. Surgery 114:1040–1049.
Jansson S, Tisell L, Lindstedt G, Lundberg P-A. 1991. Preoperative treatment with disodium pamidronate (APD) of hyperparathyroid patients with critically raised serum calcium levels. Surgery 110:480–486.
Albright F. 1934. Hyperparathyroidism. JAMA 102:1276.
Sandelin K, Tullgren O, Farnebo L. 1994. Clinical course of metastatic parathyroid cancer. World J Surg 18:594–599.
Vetto JT, Brennan MF, Woodruf J, Burt M. 1993. Parathyroid carcinoma: Diagnosis and clinical history. Surgery 114:5882–5892.
Fraker DL, Travis WD, Merendino JJ Jr, Zimering MB, Streeten EA, Weinstein LS, Marx SJ, Spiegel AM, Aurbach GD, Doppman JL, Norton JA. 1991. Locally recurrent parathyroid neoplasms as a cause for recurrent and persistent primary hyperparathyroidism. Ann Surg 213:58–65.
Rattner DW, Marrone GC, Kadson E, Silen W. 1985. Recurrent hyperparathyroidism due to implantation of parathyroid tissue. Am J Surg 149:745–748.
Sandelin K, Larsson C, Falkmer UG, Farnebo L, Grimelius L, Nordensjköld M. 1992. Morphology, DNA ploidy, and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple endocrine neoplasia type 1. Eur J Surg 158:199–206.
Harlow S, Roth SI, Bauer K, Marshall RB. 1991. Flow cytometric DNA analysis of normal and pathologic parathyroid glands. Mod Pathol 4:310–315.
Howard S, Anderson C, Diels W, Gerres K, Garcia B. 1992. Nuclear DNA density of parathyroid lesions. Pathol Res Pract 188:497–499.
August DA, Flynn SD, Jones MA, Bagwell BC, Kinder BK, 1993. Parathyroid carcinoma: The relationship of nuclear DNA content to clinical outcome. Surgery 113:290–296.
Bondeson L, Sandelin K, Grimelius L. 1993. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 17:820–829.
Obara T, Fujimoto Y, Kanaji Y, et al. 1990. Flow cytometric DNA analysis of parathyroid tumors. Cancer 66:1556–1562.
Levin KE, Chew KL, Ljung B-M, Mayhall BH, Siperstein AE, Clark OH. 1988. Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas. J Clin Endocrinol Metab 67:779–784.
Byström C, Larsson C, Blomberg C, et al. 1990. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972.
Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering M, Weinstein LS, Mc Bride WO, Nakamura Y, Brandi ML, Norton JA, Aurbach GD, Spiegel AM, Marx SJ. 1989. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213–218.
Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. 1988. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658–722.
Arnold A, Brown M, Urena P, et al. 1995. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047–2053.
Bonjer HJ, Bruining HA, Birkenhäger JC, Nishiyama RH, Jones MA, Bagwell CB. 1992. Single and multiglandular disease in primary hyperparathyroidism: Long term follow up studies, histological studies and flow cytometric DNA analysis. World J Surg 16:734.
Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A. 1995. Frequent loss of chromosome arm 1p DNA in parathyroid tumors. Genes Chromosom Cancer 13:9–17.
Szabo J, Heath B, Hill VM, Jackson CE, Zabo RJ, Mallette LE, Chew SL, Besser JM, Thaker RV, Huff V, Leppert MS, Heath H III. 1995. Hereditary hyperparathyroidism-jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944–950.
Hosokawa Y, PoUak MR, Brown EM, Arnold A. 1995. Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107–3110.
Thompson DB, Samowitz WS, Odelberg S, Davies RK, Szabo J, Heath III H. 1995. Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metabol 80:3377–3380.
Cryns VL, Thor A, Xu H-J, Wierman ME, Vickery AL, Benedict WF, Arnold A. 1994. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761.
Wassif WS, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjöld M, Peters TJ, Larsson C. 1993. Familial isolated hyperparathyroidism: A distinct genetic entity with increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485–1489.
Abbona GC, Papotti M, Gasparri G, Bussolati G. 1995. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135–138.
Dotzenrath C, Teh BT, Farnebo F, Cupistik, Svensson A, Toll A, Goretzki P, Larsson C. 1996. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81:3194–3196.
Krubsack AJ, Wilson SD, Lawson T, Kneeland JB, Thorsen K, Collier BD, Hellman RS, Isitman AT. 1989. Prospective comparison of radionucleotide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 106:639–646.
Doppman JL. 1994. Preoperative localization of parathyroid tissue in primary hyperparathyroidism. In Bilezikian JP, ed. The Parathyroids. New York: Raven Press, pp 553–565.
Hindié E, Mellière D, Simon D, Perlemuter L, Galle P. 1995. Primary hyperparathyroidism: Is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab 80:302–307.
Fugimoto Y. 1989. Parathyroid malignancy. In van Heerden J, ed. Current Problems in Endocrine Surgery. Chicago: Year Book Medical Publishers, pp 191–193.
Dubost C, Jehanno C, Lavergne A, Le Charpentier Y. 1984. Successful resection of intrathoracic metastases from two patients with parathyroid carcinoma. World J Surg 8:574–651.
Glover DJ, Shaw L, Glick JH, Slatopolsky E, Weiler C, Attie M, Goldfarb S. 1985. Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3 aminopropylamino) ethylphosphorotic acid. Ann Intern Med 103:55–57.
Warrel RPJ, Israel R, Frisone M, Snyder T, Gaynor JJ, Bockman RS. 1988. Gallium nitrate for acute treatment of cancer related hypercalcemia. Ann Intern Med 108:669–674.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sandelin, K. (1997). Parathyroid carcinoma. In: Arnold, A. (eds) Endocrine Neoplasms. Cancer Treatment and Research, vol 89. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6355-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6355-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7919-5
Online ISBN: 978-1-4615-6355-6
eBook Packages: Springer Book Archive